Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vor Biopharma Inc.”

12 pharma patents match "Vor Biopharma Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Vor Biopharma Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Vor Biopharma Inc.” · 30,257 patents in full index Clear search

  1. US 12403200

    Methods and compositions for treating autoimmune diseases

    Vor Biopharma Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  2. US 12291576

    Anti-CD45 antibodies and conjugates thereof

    Vor Biopharma Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  3. US 12251403

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  4. US 12209135

    Anti-CD45 antibodies and conjugates thereof

    Vor Biopharma Inc. · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  5. US 11975029

    Compositions and methods for inhibition of lineage specific proteins

    Vor Biopharma Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  6. US 11903973

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  7. US 11571445

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  8. US 11559551

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  9. US 11464807

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  10. US 11389485

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  11. US 11382932

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  12. US 10925902

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted